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1. Introduction
Gastrointestinal endoscopic (GIE) procedures are now performed routinely because of their
minimal invasiveness and their diagnostic and therapeutic capabilities. These procedures have
been shown to cause various effects on cardiorespiratory systems, which can increase the risks
of the procedure in patients with underlying cardiorespiratory diseases [1]. Additionally, the
complications attributed to moderate and deep sedation levels are more often associated with
cardiovascular and respiratory systems. Most predictors of cardiorespiratory-related compli‐
cations are patient-centered factors and do not vary significantly from procedure to procedure
although the procedure is complex [2].
The exact incidence of cardiorespiratory complications associated with GIE procedure is not
precisely known, but probably is quite low. Risk factors for cardiorespiratory complications
are age > 60 years, high American Society of Anesthesiologists (ASA) physical status, the use
of supplemental oxygen, inpatient status, and the involvement of a trainee in the procedure
[3,4]. Sedation-related complications during GIE procedures are commonly transient and mild
degree. The risk for these complications while providing any level of sedation or general
anesthesia is greatest when caring for the patients already medically compromised. The
significant unwanted complications can generally be prevented by careful preprocedure
assessment and preparation, appropriate monitoring and support as well as postprocedure
management.
Before undertaking any GIE procedure, endoscopists should be obtained the informed consent
from the patient, are familiar with the latest guidelines on sedation, aware of any medical,
surgical and drug history elicited in the pre-admission process as well as the risk factors should
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be identified in both out-patients and in-patients. Additionally, the physicians must be
prepared to manage these complications. Safety and monitoring should be part of a quality
assurance program for endoscopy units. This article will review the cardiovascular and
respiratory complications during moderate and deep sedation for gastrointestinal endoscopic
procedures and also address their appropriate management.
2. Cardiovascular consideration
The autonomic nervous system (ANS) plays an important role in maintaining normal hemo‐
dynamics and an adequate coronary blood flow. The sympathetic nervous system regulates
the heart rate and rhythm, increases the excitability of myocardium. The parasympathetic
nervous system regulates the heart rate and rhythm, which when stimulated can lead to sinus
bradycardia [1]. The cardiorespiratory complications account for about 50% of the potentially
serious morbidity and about 50% of all the procedure-related deaths associated with GIE
procedure. In many cases these complications are a direct or indirect consequence of elderly
or risk patients being given unnecessarily high doses of sedative and analgesic drugs [5].
2.1. Hypotension
A significant decline in blood pressure from baseline should alert the clinicians. Hypotension
is defined as the systolic blood pressure lest than 90 mmHg is due to a fall in either cardiac
output or total peripheral resistance lowering the patient's mean arterial pressure.
Episodes of hypotension in clinical practice are most commonly associated with vasovagal
events and are generally transient. However, they may become prolonged in the presence of
central nervous system depressants [6]. Blood pressure is a reflection of cardiac output and
total peripheral resistance and a fall in either or both will lower the patient’s mean arterial
pressure. In general, a systolic blood pressure of 90 mmHg should sustain mean arterial blood
pressure sufficiently to perfuse tissues in the recumbent patient. Blood pressure lower than
this combined with evidence of inadequate perfusion requires intervention.
The evaluation of tissue perfusion is the most significant component of cardiovascular
assessment. Hypotension encountered during sedation is usually attributed to either vasova‐
gal episodes or the use of sedative and anesthetic agents that depress sympathetic outflow to
the cardiovascular system. Benzodiazepines such as midazolam and diazepam, have a mild
vasodilator effect and usually produce a slight fall in arterial blood pressure even in normal
sedative doses. The combination use of a benzodiazepine and an opioid can profoundly drop
blood pressure. Propofol has been shown to be safe and effective for sedation during ERCP,
endoscopic ultrasonography (EUS) and small bowel enteroscopy, because these procedures
require more time and patient cooperation [7-11].
The cardiovascular effects of propofol include decreases in cardiac output, systemic vascular
resistance, and arterial pressure. A fall in heart rate and/or cardiac stroke volume will also
lower blood pressure. Additionally, more profound falls in blood pressure is occurred in a
Endoscopy of GI Tract14
hypovolemic patient. Propofol also has been proven to reduce postprocedural hypoxemic
events, which may be of significance in critically ill elderly patients [12] and sick pediatric
patients [13].
Prevention of this complication is to be relevant medical and drug history before the procedure,
particular detail required regarding current antihypertensive, anti-anginal and anti-arrhyth‐
mic therapy and the use of systemic corticosteroids. Additionally, blood pressure and heart
rate should be recorded before, during and after endoscopic procedure.
2.2. Hypertension
Blood pressure continuously fluctuates due to the cyclic nature of the pumping action of the
heart. The highest pressure occurs during ventricular contraction. The lowest pressure occurs
during ventricular relaxation [14]. Generally, hypertension is defined as the systolic blood
press is greater than 160 mmHg. Sudden elevations of systolic blood pressure ≥ 180 mmHg or
diastolic blood pressure ≥ 110 mmHg are generally regarded as an acute hypertensive episode
[5]. The causes of hypertension are the background systemic hypertension, anxiety or pain,
and a reflex pressor response from intubation of the esophagus. Generally, asymptomatic
patients and the patients without acute end-organ symptoms should not receive antihyper‐
tensive agents in the endoscopy unit.
2.3. Cardiac arrhythmias
Autonomic control of heart rate will respond to demands placed on the patient and may be
initiated via several baroreceptor-mediated reflexes [12]. Electrocardiogram (ECG) is also a
useful monitor for heart rate and a better assessment of heart rhythm. Continuous ECG
monitoring is recommended for high risk patient with relevant cardiac history. Cardiac
arrhythmias are frequently observed during GIE procedures. Fortunately, most of them are
not clinically significant.
In the healthy patients, a heart rate up to 120 beats/min will usually allow adequate filling.
Sinus tachycardia can be caused by patient’s anxiety or related to pain, compensatory mech‐
anism in patients who are hypotensive as a result of either dehydration or blood loss, and
following intravenous anticholinergic drugs such as buscopan.
Heart rate < 50 beats/min in healthy patients may allow for more time in diastole, but ventric‐
ular filling becomes maximized [14]. Sinus bradycardia is most frequently seen in the patients
who are taking beta blockers. It can also be induced by vagal stimulation, which occurs at the
time of intubation of the esophagus or the stretching of the sigmoid mesentery during
colonoscopy or flexible sigmoidoscopy.
2.4. Myocardial ischemia/infarction
Myocardial infarction occurs either during or in the few days after endoscopic procedures with
or without sedation. A proportion of these are undoubtedly causally related to the endoscopic
procedure. The causes of angina or myocardial Infarction are two factors; increased myocardial
oxygen demand and reduced myocardial perfusion [6].
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Increased myocardial oxygen demand is due to an increase in the mean arterial blood pressure
and heart rate. This can cause angina in the patients with ischemic heart disease or occult
symptomless myocardial ischemia. Additionally, marked hypertension and/or tachycardia
increase myocardial oxygen consumption. In the other way, hypotension and/or bradycardia
reduce myocardial perfusion. Stress-induced myocardial ischemia can occur even in the
patients with or without clinically significant coronary disease [15]. This myocardial ischemia
is related to the activation of the sympathetic nervous system, resulting in hemodynamic
changes causing an increase in cardiac demand.
Prevention or minimization of myocardial ischemia/infarction during GIE procedure
1. Pre-oxygenation in risk patients and give continuous supplemental oxygen
2. Give patients on their normal anti-hypertensive and/or anti-anginal therapy right up to
the time of the endoscopy
3. Angina developing during an endoscopy is usually best managed by giving sublingual
nitroglycerine, oxygen supplementation and discontinuing the examination
4. If angina or myocardial infarction is suspected during or following an endoscopy, arrange
an electrocardiogram to exclude an myocardial infarction
3. Respiratory considerations
Airway management is the most important aspect of patient care and examination of the
patient’s airway is an essential component of the preoperative assessment. Mallampati class
correlates with increased difficulty in airway management. High oxygen concentration is
indicated for patients who are spontaneously breathing, regardless of their level of conscious‐
ness during medical urgencies and emergencies. The equipment required to provide supple‐
mental oxygen includes a 100% oxygen source, a regulator, tubing, and either a nasal cannula
or mask. Every office should be equipped with a portable E-cylinder of oxygen.
3.1. Respiratory depression
Higher dose of benzodiazepine and/or opioid is also the greater the percentage benzodiazepine
and/or opioid receptor occupancy in the central nervous system the greater is the degree of
depression of consciousness. Intravenous benzodiazepines such as midazolam and diazepam
can cause respiratory depression. Intravenous opioids such as pethidine and fentanyl occupy
opioid receptor sites within the brain and brainstem and can similarly cause respiratory
depression [6]. Drug induced hypoventilation may cause both hypoxemia and CO2 retention.
Pulse oximetry is a very useful indicator of oxygenation but not ventilation. However when
supplemental oxygen is used, the fall in SpO2 may be significantly delayed for between 30-90
seconds. So that continuous capnography monitoring is recommended in the patients being
sedated with propofol [16]. As for over-sedation, loss of verbal contact due to reduced
conscious level may be the first sign of impending respiratory depression. Reduction in
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SpO2 on pulse oximetry is a good indicator but it can be a late sign of respiratory depression.
Increased PaCO2 is the most sensitive early warning of respiratory depression [17].
Management of oversedation is to stimulate the patient to wake up and take deep breaths both
verbally and/or light shaking. If the patients are not responding then benzodiazepine antag‐
onist such as flumazenil and/or opioid antagonist such as naloxone may be required. The
airway may need to be protected with chin lift, jaw thrust, and, if necessary, airway or laryngeal
mask [6].
3.2. Airway obstruction
Although, obstruction may result in hypoventilation and hypoxia. Airway obstruction must be
distinguished from respiratory depression. Hypoxia is common in patients undergoing upper
GIE procedure with or without sedation. Sedation significantly increases the incidence of desa‐
turation and hypoxia. Supplementary nasal oxygen at 3 litres/min in sedated patients abolishes
desaturation and hypoxia. Upper airway obstruction may be attributed to anatomical struc‐
tures or foreign body [18]. Independent predictors of airway modifications include male sex,
American Society of Anesthesiologists class of III or higher, and increased body mass index [19].
Laryngospasm is a reflex closure or spasm of the glottic muscles including the false and true
vocal cords. It is more likely during deep sedation. Laryngospasm occurs more frequently in
adults who are smokers. Bronchospasm is a lower airway obstruction due to contraction or
spasm of the bronchial smooth muscle. It may be a result of an anaphylactoid reaction or a
consequence of a hyper-reactive airway in the asthmatic patients [18]. Management of
laryngospasm and bronchospasm depends on the severity and the causes of them.
3.3. Hypoxia
Hypoxia may be a consequence of respiratory depression or airway obstruction. The incidence
of hypoxia is up to 1.5% to 70%, which make it the most common cardiorespiratory adverse
event during the endoscopy [20]. Hypoxemia can lead to many complications, depending on
the severity of hypoxemic attack. The use of supplemental oxygen during GIE procedure is
routinely used by many endoscopists. However, oxygen supplementation will delay the
detection of apnea and hypoxia [4]. Additionally, in patients given supplemental oxygen,
saturation may be maintained in the progression of hypercapnia.
Multivariable logistic regressions revealed that independent risk factors for hypoxemia
include high body mass index, hypertension, diabetes, gastrointestinal diseases, heart diseases
and the procedures that combined esophagogastroduodenoscopy (EGD) and colonoscopy
[21]. Hypoxemia occurs typically within 5 min of medication administration or endoscope
intubation and only one third of all apnea and abnormal ventilation events eventually lead to
hypoxemia [20].
3.4. Pulmonary aspiration
Aspiration of gastric contents into the lungs during GIE procedure is relatively common. It
may cause pneumonia and may result in death. Risk factors for aspiration are the elderly
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patients, over-sedated patients, the patients with gastrointestinal bleeding, gastric stasis,
gastric outlet obstruction, patients with hepatic encephalopathy, and the patients who have
full stomach. Aspiration can also occur when a local anesthetic spray is used in combination
with intravenous sedation [6].
Aspiration may be suspected when a patient starts coughing violently either during or soon
after an endoscopic procedure and cyanosis may occur. Although the higher incidence of
pulmonary aspiration because of the better sensitivity of 2-[18F] fluoro-2-deoxy-D-glucose
positron tomography. However, the low incidence of clinical events needed intervention may
still reflect the safety of sedation used for gastrointestinal endoscopy [22]. Treatments of
pulmonary aspiration include suction of fluids from oral cavity and throat, increasing the rate
of supplemental oxygen, encouraging the patient to cough, chest film, antibiotics and physi‐
otherapy.
4. Patients requiring anesthesiologists support for GIE procedures
Generally, GIE procedures can be performed by using topical anesthesia, intravenous sedation
and general anesthesia [23-25]. The topical anesthesia and intravenous sedation techniques
can be effectively done by non-anesthetic personnel. However, non-anesthetic personnel
should be sedated the patients only in mild and moderate (conscious) sedation levels [26].
Elective cases – Indications include:
1. Hypotension (systolic blood pressure < 90 mmHg) due to a fall in cardiac output or total
peripheral resistance
2. Patients with severe cardiac and/or pulmonary abnormalities
3. Patients with severe learning difficulties
4. Patients with history of failed sedation
5. Patients who may prove difficult to sedate such as alcoholic or drug addicted patients
6. Patients with poor venous access
7. Phobic or uncooperative patients such as children, dementia patients and psychiatric
patients
8. Patient being sedated with intravenous propofol
Emergency cases- with high risk of aspiration and requiring endotracheal tube with general
anesthesia include:
1. Patients with depressed levels of consciousness
2. Patients associated with encephalopathy
3. Patients suspected bleeding varices
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4. Patients with severe cardiac and/or pulmonary abnormalities
5. Patients unlikely to cooperate during endoscopy procedure
5. Postprocedural period
Most of cardiorespiratory adverse events occur during the GIE procedure. Standard monitor‐
ing including non-invasive blood pressure, heart rate, pulse oxymetry and electrocardiogram
is also routinely used in the postprocedural period. Postprocedural nausea/vomiting and pain
need to be rescued especially in the ambulatory patients. Fortunately, a lower incidence of
procedural nausea/vomiting and pain after the GIE procedure is observed even in the
therapeutic endoscopy [27]. Opioid and cyclo-oxygenase-2-inhibitor can be safely and
effectively used for procedural pain in the GIE patients [28].
My previous study showed that periodic objective evaluation of home-readiness revealed that
the majority of patients would achieve a satisfactory score on or before 1 hour after the GIE
procedure [29]. So that, the patients underwent GIE procedures should be admitted in the
recovery room unit at least 30-60 min before discharge. The time to home-readiness by objective
evaluation correlated with the type of procedure. Most delay after satisfactory home-readiness
scores were reached, were due to non-medical reasons.
Sedation-related cardiorespiratory complications also occur immediately after the GIE
procedure. The types of complications in the postprocedural period are similar as in the
intraprocedural period. The patients who receive benzodiazepine and/or opioid antagonists
should to be closely observed in the recovery room unit longer than the other patients.
6. Summary
Although the serious adverse events are rare for the GIE procedural sedation. However, the
cardiorespiratory-related complications are common. These complications may be severe if
the physicians do not detect and treat the patients earlier. An adequate preprocedural history
should be obtained and physical examination performed on all patients. Particular attention
should be paid to the patient’s physical status and cardiorespiratory system. Appropriate
preprocedural assessment and optimization of the patients undergoing moderate or deep
sedation are essential to minimize complications. Periodical assessment of the level of sedation
and continuous monitoring of cardiovascular and respiratory systems provides timely
information. Pulse oxymetry and oxygen supplementation are recommended for the reduction
of hypoxemia. Capnography monitoring is considered in the patients undergoing prolonged
endoscopic procedures who are at risk of deep sedation. Additionally, the standardized
discharge criteria should be used to determine the patient’s readiness for discharge. Lastly,
the physicians should remember that the risk for un-intended deeper level of sedation may be
more common after the stimulation of the endoscopic procedure has been removed.
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